{"slug":"selank-brain-fog","verification":{"valid":true,"entries":2,"head":"dafa3b3bf2369af6606a0baa240be21257d4803de1e3172df839c120f6a63520"},"count":2,"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"The effect of selank (30 patients) was compared to that of medazepam (32 patients).","summary":"Human trial comparing Selank and medazepam in 62 patients with GAD/neurasthenia; similar anxiolytic efficacy with Selank showing additional benefits.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:49:01.757Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"581fb906b250c199e21e53244385049058e6014fb7aa10d4270cadfa914e6843"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31625062/","title":"Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats","quote":"Selank (0.3 mg/kg a day, 7 days, intraperitoneally) produced a cognitive-stimulating effect in 9 months rats not exposed to ethanol.","summary":"Rodent study on Selank, BDNF, and memory protection in ethanol model.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:49:01.757Z","link_status":"ok","quote_status":"unverified","prev":"581fb906b250c199e21e53244385049058e6014fb7aa10d4270cadfa914e6843","hash":"dafa3b3bf2369af6606a0baa240be21257d4803de1e3172df839c120f6a63520"}]}